Investors' Confidence in DexCom (DXCM) Rises as Growth Outlook Reassured
Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be downloaded here.
Dexcom Inc (DXCM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 71,846 | $4,838,828 | -88% | 1.3% |
| 2. | Taproot Management David Lin And Jason Beverage | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.43 | 2,500 | $138,563.00 | 331,697 | 2025-11-10 | Filing | |
| $54.98 | 15,700 | $863,138.90 | 329,197 | 2025-11-10 | Filing | |
| $50.01 | 25,000 | $1,250,250.00 | 58,502 | 2017-11-07 | Filing | |
| $49.61 | 10,000 | $496,100.00 | 33,502 | 2017-11-06 | Filing | |
| $15.50 | 70,000 | $1,085,000.00 | 121,975 | 2013-03-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $76.32 | 26,756 | $2,041,999.19 | 328,970 | 2026-07-20 | Filing | |
| $74.42 | 1,700 | $126,514.00 | 104,653 | 2026-07-15 | Filing | |
| $72.00 | 26,756 | $1,926,432.00 | 355,726 | 2026-07-06 | Filing | |
| $75.55 | 1,700 | $128,435.00 | 106,353 | 2026-06-15 | Filing | |
| $74.82 | 199 | $14,888.92 | 52,852 | 2026-06-15 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,204,553 | $81,126,645 | 0.87% | |
| 2. | 1,166,132 | $78,538,991 | 0.07% | |
| 3. | 957,366 | $64,478,600 | 0.04% | |
| 4. | 867,009 | $58,393,062 | 1.41% | |
| 5. | 840,950 | $56,637,983 | 1.61% |
News See All
10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds
On June 9, Reuters reported that Philips' Future Health Index survey concluded that artificial intelligence improved clinical accuracy and increased patient capacity.
12 High Quality Stocks to Buy for the Long Term
High-quality stocks are getting more attention as investors look for companies that can keep growing earnings without depending only on market momentum.
Analysts Upgrade DexCom (DXCM) to “Outperform,” Driving Share Recovery
Alpha Wealth Funds, LLC, an investment management company, released its Q1 2025 letter for the “Insiders Fund”. A copy of the letter can be downloaded here.
10 Stocks Dominating With Powerful Gains
The stocks defied a lackluster performance on Wall Street, with all three major indices ending in the red.
12 Best Growth Stocks to Invest In for the Next 2 Years
On May 1, Chris Harvey, CIBC, joined CNBC's 'Closing Bell' to discuss the surprising speed of the market's recovery, noting that while he expected equities to rise and saw a buying opportunity, the move...
DexCom, Inc. (NASDAQ:DXCM) Q1 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to the DexCom, Inc. First Quarter 2026 Earnings Release Conference Call. My name is Abby, and I will be your operator for today's call.
BTIG Remains Bullish on DexCom, Inc. (DXCM)
DexCom, Inc. (NASDAQ:DXCM) is one of the best medical device stocks to invest in right now. BTIG cut the price target on DexCom, Inc.
10 Best Medical Device Stocks to Invest In Right Now
On April 27, Tom Lee, Fundstrat Capital Chief Investment Officer and Bitmine Immersion Technologies Chairman, appeared on CNBC's ‘Power Lunch’ to discuss the outlook for equity markets.
Is DexCom, Inc. (DXCM) A Good Stock To Buy Now?
Is DXCM a good stock to buy? We came across a bullish thesis on DexCom, Inc. on Part-Time Compounder’s Substack by Francesco Ferrari.